Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co., Ltd. (PHH) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · PHH · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Park Ha Biological Technology Co., Ltd. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
Recent insider transactions
PHH executive sell shares · PHH board member insider trading · PHH insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 4, 2018 | Bogansky Michael R SVP & CFO | Other | 13,074 | $144K | Form 4 |
| Oct 4, 2018 | STEIN KEVIN Director | Other | 5,467 | $60K | Form 4 |
| Oct 4, 2018 | PIZZI CHARLES P Director | Other | 28,053 | $309K | Form 4 |
| Oct 4, 2018 | Neuhauser James C Director | Other | 7,942 | $87K | Form 4 |
| Oct 4, 2018 | CROWL ROBERT B CEO · Director | Other | 88,238 | $971K | Form 4 |
| Oct 4, 2018 | Carlin Jane D Director | Other | 34,228 | $377K | Form 4 |
| May 22, 2018 | CROWL ROBERT B CEO · Director | Other | 9,599 | $103K | Form 4 |
| May 22, 2018 | Bogansky Michael R SVP & CFO | Other | 4,226 | $46K | Form 4 |
| Apr 2, 2018 | STEIN KEVIN Director | Sale | 825 | $9K | Form 4 |
| Feb 25, 2018 | CROWL ROBERT B CEO · Director | Other | 1,559 | $14K | Form 4 |
| Feb 25, 2018 | Bogansky Michael R SVP & CFO | Other | 314 | $3K | Form 4 |
| Jan 2, 2018 | STEIN KEVIN Director | Sale | 825 | $8K | Form 4 |
| Oct 2, 2017 | STEIN KEVIN Director | Sale | 825 | $12K | Form 4 |
| Sep 23, 2017 | CROWL ROBERT B CEO · Director | Other | 18,153 | $245K | Form 4 |
| Sep 11, 2017 | PIZZI CHARLES P Director | Sale | 8,844 | $126K | Form 4 |
| Jun 28, 2017 | Carlin Jane D Director | Award | 8,639 | — | Form 4 |
| Jun 28, 2017 | PIZZI CHARLES P Director | Award | 8,639 | — | Form 4 |
| Jun 28, 2017 | Neuhauser James C Director | Award | 7,942 | — | Form 4 |
| Jun 28, 2017 | STEIN KEVIN Director | Award | 7,942 | — | Form 4 |
| May 22, 2017 | Bogansky Michael R SVP & CFO | Other | 4,490 | $61K | Form 4 |
| May 22, 2017 | CROWL ROBERT B EVP & COO | Other | 10,043 | $137K | Form 4 |
| Feb 25, 2017 | CROWL ROBERT B EVP & CFO | Other | 1,182 | $15K | Form 4 |
| Feb 25, 2017 | Bogansky Michael R SVP & Controller | Other | 330 | $4K | Form 4 |
| Nov 21, 2016 | CROWL ROBERT B EVP & CFO | Other | 12,222 | $178K | Form 4 |
| Nov 18, 2016 | CROWL ROBERT B EVP & CFO | Other | 15,276.75 | $227K | Form 4 |
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About PHH insider trading
PHH insider trades
Park Ha Biological Technology Co., Ltd. (PHH) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including PHH. Over the past 12 months, 0 insiders have filed transactions with the SEC. PHH insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Park Ha Biological Technology Co., Ltd.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
PHH insider trading · 5 questionsThe insiders of Park Ha Biological Technology Co., Ltd. (PHH) include executives and directors such as PHH, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026